Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 07, 2020 08:00 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals Inc. Receives Complete Response Letter from FDA for FUROSCIX®

BURLINGTON, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
November 19, 2020 08:00 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals to Present at the 3rd Annual Evercore ISI Virtual HealthCONx Conference

BURLINGTON, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
November 16, 2020 07:00 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

Commercialization preparedness activities continuing ahead of December 30 PDUFA date for FUROSCIX® (furosemide injection) for subcutaneous administration Enrolled first patient in FREEDOM-HF...
November 11, 2020 08:00 ET | Source: scPharmaceuticals, Inc.

scPharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference

BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...